United States · Venture startup
7 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$44Mraised across 7 rounds since 2005, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
ATDC
SR One
Frazier Healthcare Partners
H.I.G. CapitalFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
ATDCSR OneFrazier Healthcare PartnersH.I.G. CapitalMedImmune VenturesThe Aurora FundsCM Capital InvestmentsGeorgia Venture PartnersCentrosome VenturesMissing a round, or an investor who was in one? Tell us.
Altiris Therapeutics's investors include ATDC, SR One, Frazier Healthcare Partners, H.I.G. Capital and MedImmune Ventures, and 4 more on record.
Altiris Therapeutics has raised $44M across 7 rounds since 2005. 3 rounds did not disclose an amount, so the total is a floor.
Altiris Therapeutics's most recent round was a Venture in Feb 2009.
Altiris Therapeutics's largest round on record is $35M (Series B), in Oct 2007.
Altiris Therapeutics's first round on record, in Sept 2005, was backed by ATDC.
Altiris Therapeutics's latest named round is a Venture, in Feb 2009.
Altiris Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
